REQUEST A DEMO
Total
USD $0.00
Search more companies

Arensia Exploratory Medicine SRL (Romania)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Arensia Exploratory Medicine SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Arensia Exploratory Medicine SRL is based in Romania, with the head office in Bucharest. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on September 21, 2007. There are currently 102 (2022) people employed by Arensia Exploratory Medicine SRL. The latest financial highlights indicate a net sales revenue increase of 53.59% in 2023. During that time, Arensia Exploratory Medicine SRL’s total assets grew by 44.08%. Arensia Exploratory Medicine SRL’s net profit margin decreased by 7.44% in 2023.

Headquarters
Strada Banul Antonache Nr. 40-44
Bucharest; Bucharest; Postal Code: 011665

Contact Details: Purchase the Arensia Exploratory Medicine SRL report to view the information.

Basic Information
Total Employees:
Purchase the Arensia Exploratory Medicine SRL report to view the information.
Outstanding Shares:
Purchase the Arensia Exploratory Medicine SRL report to view the information.
Registered Capital:
Purchase the Arensia Exploratory Medicine SRL report to view the information.
Incorporation Date:
September 21, 2007
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Arensia Exploratory Medicine SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
53.59%
Total operating revenue
53.53%
Operating profit (EBIT)
-28.25%
EBITDA
-13.8%
Net Profit (Loss) for the Period
-30.03%
Total assets
44.08%
Total equity
50.63%
Operating Profit Margin (ROS)
-8.89%
Net Profit Margin
-7.44%
Return on Equity (ROE)
-32.29%
Quick Ratio
0.57%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?